An expanding body of research indicates that aerobic exercise and strength-training can improve the chances of survival.

Medical advancements make early-detected cancers more manageable and treatable, with immunotherapy and CAR T cell therapy ...

A collaborative effort between Mount Sinai and Memorial Sloan Kettering Cancer Center has shed valuable light on how ...

Nearly half of all new cancer drugs approved by the U.S. Food and Drug Administration (FDA) over the past quarter-century ...

Eligibility for treatment with the latest cancer drugs is often determined by genetic mutations in tumors, criteria that leave minority patients at a disadvantage due to their under-representation in ...

An AI system developed to predict a patient's response to immunotherapy could help "democratize" access to the pricey drugs ...

A collaborative effort between Mount Sinai and Memorial Sloan Kettering Cancer Center has shed valuable light on how monoamine neurotransmitters such as serotonin, dopamine, and now histamine help ...

A collaborative effort has shed valuable light on how monoamine neurotransmitters such as serotonin, dopamine, and now histamine help regulate brain physiology and behavior through chemical bonding of ...

Research suggests the benefits of testosterone therapy after prostate cancer surgery in select men may outweigh risks.

Researchers at The Tisch Cancer Institute at Mount Sinai, in collaboration with Memorial Sloan Kettering Cancer Center (MSK), ...

In an intriguing revelation from recent research, mitochondria have been shown not only to power the cell but also to ...